COVID-19 raises questions about the value of personalised medicine

Wall Street Journal

8 May 2020 - A group of medical dissenters argues that tailoring treatment to the genetic profiles of individuals, a longstanding goal for researchers, is less important than the old-fashioned public health measures being used against the pandemic.

The medical world is known for its fractious debates. One of the longest running is between those who believe that more lives will be saved by a “one-size-fits-all” approach, based on public health strategies, and those who see greater promise in treatments and care tailored to each individual’s genetic code.

“If we are to advance health care in the United States, where is the dollar best spent?

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder